by Jessica Casebolt | May 10, 2023 | Life Sciences, Tea Leaves
Some of the world’s biggest drugmakers are laying legal groundwork to fight the U.S. plan to negotiate drug prices for its Medicare health coverage, including the argument that a ban against speaking about these talks violates constitutional rights, according to six...
by Jessica Casebolt | May 8, 2023 | Life Sciences, Tea Leaves
As U.S. health regulators are weighing thefirst-ever request to make a birth control pill available without a prescription, Food and Drug Administration (FDA) scientists on Friday expressed skepticism about whether the birth control pill can be switched from...
by Jessica Casebolt | May 4, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) on Wednesday approved the first vaccine to prevent infections caused by respiratory syncytial virus, or RSV, a widespread pathogen that can be deadly in young children and older adults. Approval of the vaccine, which was...
by Jessica Casebolt | May 2, 2023 | Life Sciences, Tea Leaves
A new bipartisan bill seeks to limit drug shortages by staying ahead of new demand increases. Florida Rep. Cory Mills and California Rep. Sara Jacobs filed a bill on April 28 that, if passed, would require drugmakers to tell the Food and Drug Administration (FDA) if...
by Jessica Casebolt | Apr 28, 2023 | Life Sciences, Tea Leaves
A bipartisan coalition of representatives and senators introduced legislation that would pay drug manufacturers to develop antibiotics and antifungal drugs to treat drug-resistant bacteria and fungi, as many companies stopped making the medications because the...
by Jessica Casebolt | Apr 26, 2023 | Life Sciences, Tea Leaves
Yesterday, senate health committee leaders Bernie Sanders and Bill Cassidy announced an agreement on a bipartisan package to increase access to generic drugs and increase transparency required of pharmacy benefit managers (PBMs).The package includes four bills that...
Recent Comments